title: Ofatumumab: another way to target CD20 in Waldenström's macroglobulinaemia?
authors.affiliation: Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, 89081, Germany. Electronic address: christian.buske@uni-ulm.de.
authors.forename: Christian
authors.initials: C
authors.lastname: Buske
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018951:Antigens, CD20 / Q000276:immunology; D000074322:Antineoplastic Agents, Immunological / Q000276:immunology / Q000627:therapeutic use*; D006801:Humans; D058990:Molecular Targeted Therapy; D000069283:Rituximab / Q000276:immunology / Q000627:therapeutic use; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018951:Antigens, CD20; D000074322:Antineoplastic Agents, Immunological; D000069283:Rituximab; C527517:ofatumumab